Owing to the following health risks, CJC-1295 and ipamorelin are moderately unsafe for the general population compared to some of the other peptides weve studied: Immunogenicity: Immunogenicity is a condition in which your body interprets a substance as a threat and mounts an immune response against it
Currently, BPC-157 is on the World Anti-Doping Agency Prohibited List
Not intended for individuals under 18. Consult a healthcare professional before use, especially if pregnant, nursing, or managing medical conditions such as anemia or neurological disorders
This is the central regulatory problem that full FDA approval would need to solve and it is the reason PCAC reviews for peptides like BPC-157 often hinge on available safety data rather than efficacy evidence from controlled human studies
BPC-157's gastric origin gives it natural relevance to gut research, and published work has characterised its activity in models of gastric ulceration, intestinal anastomosis, and inflammatory bowel injury
